Loading...
DH logo

Definitive Healthcare Corp.NasdaqGS:DH Stock Report

Market Cap US$571.4m
Share Price
US$4.03
My Fair Value
US$4.54
11.2% undervalued intrinsic discount
1Y-14.1%
7D-0.7%
Portfolio Value
View

Definitive Healthcare Corp.

NasdaqGS:DH Stock Report

Market Cap: US$571.4m

Definitive Healthcare (DH) Stock Overview

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. More details

DH fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

DH Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Definitive Healthcare Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Definitive Healthcare
Historical stock prices
Current Share PriceUS$4.03
52 Week HighUS$5.68
52 Week LowUS$2.15
Beta1.64
1 Month Change0.75%
3 Month Change21.75%
1 Year Change-14.07%
3 Year Change-78.61%
5 Year Changen/a
Change since IPO-90.69%

Recent News & Updates

Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Aug 19
Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Definitive Health Q2 Revenue Beats Expectations: Why I'm Upgrading The Stock To A Hold

Aug 18

Recent updates

Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Aug 19
Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Definitive Health Q2 Revenue Beats Expectations: Why I'm Upgrading The Stock To A Hold

Aug 18
User avatar

Improved Data Integration And Healthcare Partnerships Will Create Value

Enhancing data integration and customer retention efforts is expected to boost customer relationships, stabilize churn rates, and positively impact revenue and margins.

Definitive Healthcare Corp.'s (NASDAQ:DH) Shares Climb 27% But Its Business Is Yet to Catch Up

Feb 11
Definitive Healthcare Corp.'s (NASDAQ:DH) Shares Climb 27% But Its Business Is Yet to Catch Up

A Dive Into Definitive Healthcare

Feb 04

Is Definitive Healthcare (NASDAQ:DH) Weighed On By Its Debt Load?

Jan 14
Is Definitive Healthcare (NASDAQ:DH) Weighed On By Its Debt Load?

Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things

Aug 19

More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%

Aug 01
More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%

Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound

Jun 25

Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%

May 30
Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%

Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Apr 14
Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now

Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25

Mar 19

Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

Feb 16
Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?

An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Dec 29
An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued

Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Nov 24
Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Jun 02
Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 06
Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholder Returns

DHUS Healthcare ServicesUS Market
7D-0.7%-4.1%-0.009%
1Y-14.1%16.8%15.8%

Return vs Industry: DH underperformed the US Healthcare Services industry which returned 18% over the past year.

Return vs Market: DH underperformed the US Market which returned 17.2% over the past year.

Price Volatility

Is DH's price volatile compared to industry and market?
DH volatility
DH Average Weekly Movement7.3%
Healthcare Services Industry Average Movement9.8%
Market Average Movement6.4%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.0%

Stable Share Price: DH has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: DH's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011782Kevin Coopwww.definitivehc.com

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management.

Definitive Healthcare Corp. Fundamentals Summary

How do Definitive Healthcare's earnings and revenue compare to its market cap?
DH fundamental statistics
Market capUS$571.35m
Earnings (TTM)-US$304.75m
Revenue (TTM)US$244.93m
1.7x
P/S Ratio
-1.4x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DH income statement (TTM)
RevenueUS$244.93m
Cost of RevenueUS$39.99m
Gross ProfitUS$204.94m
Other ExpensesUS$509.69m
Earnings-US$304.75m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-2.93
Gross Margin83.67%
Net Profit Margin-124.43%
Debt/Equity Ratio41.1%

How did DH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/29 19:39
End of Day Share Price 2025/08/29 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Definitive Healthcare Corp. is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Saket KaliaBarclays
Allen LutzBofA Global Research